SUN Pharmaceutical Industries Limited — Capecitabine Exporter Profile
Indian Pharmaceutical Exporter · #7 for Capecitabine · $2.9M export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #7 Indian exporter of Capecitabine with $2.9M in export value and 57 verified shipments. SUN Pharmaceutical Industries Limited holds a 3.2% market share in Capecitabine exports across 10 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Capecitabine Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Capecitabine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $963.0K | 28 | 44.4% |
| PHILIPPINES | $450.0K | 9 | 20.8% |
| BRAZIL | $441.0K | 10 | 20.3% |
| SOUTH AFRICA | $88.3K | 2 | 4.1% |
| ISRAEL | $73.6K | 2 | 3.4% |
| PERU | $51.5K | 2 | 2.4% |
| COLOMBIA | $31.5K | 1 | 1.5% |
| MYANMAR | $28.8K | 1 | 1.3% |
| VIETNAM, DEMOCRATIC REP. OF | $25.2K | 1 | 1.2% |
| UNITED STATES | $14.1K | 2 | 0.6% |
SUN Pharmaceutical Industries Limited exports Capecitabine to 10 countries. The largest destination is CANADA accounting for 44.4% of SUN Pharmaceutical Industries Limited's Capecitabine shipments, followed by PHILIPPINES (20.8%) and BRAZIL (20.3%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Capecitabine from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TARO PHARMACEUTICALS INC. | CANADA | $469.1K | 13 |
| TARO PHARMACEUTICALS INC | CANADA | $360.5K | 11 |
| SUN PHARMA PHILIPPINES INC. | PHILIPPINES | $300.0K | 6 |
| M/S. SUN FARMACEUTICA DO BRAZIL LTD | BRAZIL | $246.0K | 5 |
| SUN PHARMA PHILIPPINES INC | PHILIPPINES | $150.0K | 3 |
| M S SUN FARMACEUTICA DO BRAZIL LTD | BRAZIL | $100.0K | 2 |
| RANBAXY PHARMACEUTICALS PTY LIMITED | SOUTH AFRICA | $88.3K | 2 |
| TARO PHARMACEUTICALS INC., | CANADA | $83.5K | 3 |
| SUN FARMACEUTICA DO BRAZIL LIMITED | BRAZIL | $50.0K | 1 |
| M S TARO PHARMACEUTICALS INC | CANADA | $50.0K | 1 |
SUN Pharmaceutical Industries Limited supplies Capecitabine to 20 buyers globally. The largest buyer is TARO PHARMACEUTICALS INC. (CANADA), followed by TARO PHARMACEUTICALS INC (CANADA) and SUN PHARMA PHILIPPINES INC. (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Capecitabine Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $32.0M worth of Capecitabine through 2,246 shipments from 216 suppliers to 123 countries, serving 516 buyers globally. SUN Pharmaceutical Industries Limited contributes $2.9M to this total, accounting for 3.2% of India's Capecitabine exports. SUN Pharmaceutical Industries Limited ships Capecitabine to 10 countries through 20 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Capecitabine Exports?
SUN Pharmaceutical Industries Limited's average Capecitabine shipment value is $50.0K per consignment, based on 57 shipments totaling $2.9M. The largest destination is CANADA (44.4% of SUN Pharmaceutical Industries Limited's Capecitabine exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Capecitabine Exporters?
SUN Pharmaceutical Industries Limited ranks #7 among 216 Indian Capecitabine exporters with a 3.2% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($7.4M), INTAS PHARMACEUTICALS LIMITED ($5.0M), EUGIA PHARMA SPECIALITIES LIMITED ($4.0M). SUN Pharmaceutical Industries Limited processed 57 shipments to 10 destination countries.
What Capecitabine Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TARO- CAPECITABINE 500 MG (BLISTER PACK) | $400.0K | 8 |
| CAXETA 500 TABLETS (CAPECITABINE TABLETS | $200.0K | 4 |
| CAXETA TAB 500MG 120S SA CAPECITABINE TABLETS 500 MGPACK : 12*10 SAP CODE : 1156105 HSN CODE : 30049049 | $88.3K | 2 |
| TARO- CAPECITABINE 500 MG (BOTTEL PACK)- | $74.6K | 2 |
| TARO- CAPECITABINE 500 MG (BOTTEL PACK) | $64.1K | 2 |
| TARO CAPECITABINE 500 MG BLISTER PACKBATCH HAE0320A MFD 01 02 2023 EXP 31 01 2025 | $50.0K | 1 |
| CAXETA 500 TABLETS CAPECITABINE TABLETS500 MG ACT QTY 2326 PACKX10X10S | $50.0K | 1 |
| CAPECITABINE 500MG TABLETS PACK:BOX12X10S BATCH:HAE1404A HAE1405A HAE1669A HAE1670A EACH CONTS.CAPECITABINA TABLETS 5 | $50.0K | 1 |
| TARO-CAPECITABINE 500 MGBLISTER PACK PACK:12*10 BATCH:HAD3749A | $50.0K | 1 |
| CAXETA 500 TABLETS (CAPECITABINE TABLETS500 MG) PACK : BOX10X10S SAP CODE : 1121211 | $50.0K | 1 |
SUN Pharmaceutical Industries Limited exports 42 distinct Capecitabine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TARO- CAPECITABINE 500 MG (BLISTER PACK) with 8 shipments worth $400.0K.
Regulatory Requirements: Exporting Capecitabine to Key Markets
What SUN Pharmaceutical Industries Limited must comply with to export Capecitabine to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Capecitabine Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | EUGIA PHARMA SPECIALITIES LIMITED | $4.0M | 80 | 7 | $50.0K |
| 1 | MANKIND PHARMA LIMITED | $2.9M | 58 | 1 | $50.0K |
| 7 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $2.9M | 57 | 10 | $50.0K |
| 6 | JODAS EXPOIM PRIVATE LIMITED | $1.9M | 37 | 3 | $50.0K |
| 9 | RELIANCE LIFE SCIENCES PRIVATE LIMITED | $1.4M | 68 | 14 | $19.9K |
SUN Pharmaceutical Industries Limited ranks #7 among 216 Indian Capecitabine exporters. Average shipment value of $50.0K compared to the market average of $148.1K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and MANKIND PHARMA LIMITED.
Which Indian Ports Ship Capecitabine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 359 | 16.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 283 | 12.6% |
| DELHI AIR CARGO ACC (INDEL4) | 233 | 10.4% |
| HYDERABAD ICD (INSNF6) | 173 | 7.7% |
| HYDERABAD AIR | 154 | 6.9% |
| DELHI AIR | 142 | 6.3% |
| HYDERABAD ACC (INHYD4) | 89 | 4.0% |
| Bombay Air | 80 | 3.6% |
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Capecitabine Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Capecitabine, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Capecitabine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Capecitabine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 58 individual customs records matching SUN Pharmaceutical Industries Limited exporting Capecitabine, covering 42 formulations to 10 countries via 20 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 516+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Capecitabine Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Capecitabine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Capecitabine Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Capecitabine. For current shipment-level data, contact TransData Nexus.